CNS regulation of appetite

[1]  A. Gozzi,et al.  Brain reinforcement system function is ghrelin dependent: studies in the rat using pharmacological fMRI and intracranial self‐stimulation , 2012, Addiction biology.

[2]  P. Matthews,et al.  The Gut Hormones PYY3-36 and GLP-17-36 amide Reduce Food Intake and Modulate Brain Activity in Appetite Centers in Humans , 2011, Cell metabolism.

[3]  A. Abizaid,et al.  Motivation to obtain preferred foods is enhanced by ghrelin in the ventral tegmental area , 2011, Hormones and Behavior.

[4]  A. Dossat,et al.  Glucagon-Like Peptide 1 Receptors in Nucleus Accumbens Affect Food Intake , 2011, The Journal of Neuroscience.

[5]  D. Richard,et al.  Involvement of the opioid system in the orexigenic and hedonic effects of melanin-concentrating hormone. , 2011, American journal of physiology. Regulatory, integrative and comparative physiology.

[6]  J. Elmquist,et al.  Serotonin 2C Receptor Activates a Distinct Population of Arcuate Pro-opiomelanocortin Neurons via TRPC Channels , 2011, Neuron.

[7]  H. Grill,et al.  Hippocampal Leptin Signaling Reduces Food Intake and Modulates Food-Related Memory Processing , 2011, Neuropsychopharmacology.

[8]  S. Kersten,et al.  Saturated fatty acids and snoRNAs: partners in crime. , 2011, Cell metabolism.

[9]  S. Dickson,et al.  The role of the central ghrelin system in reward from food and chemical drugs , 2011, Molecular and Cellular Endocrinology.

[10]  S. Taha,et al.  mu-Opioid receptor stimulation in the nucleus accumbens elevates fatty tastant intake by increasing palatability and suppressing satiety signals. , 2011, American journal of physiology. Regulatory, integrative and comparative physiology.

[11]  H. Raybould,et al.  Effect of ghrelin receptor antagonist on meal patterns in cholecystokinin type 1 receptor null mice , 2011, Physiology & Behavior.

[12]  J. A. López-Moreno,et al.  Additive effects of cannabinoid CB1 receptors blockade and cholecystokinin on feeding inhibition , 2011, Pharmacology Biochemistry and Behavior.

[13]  P. Pfluger,et al.  Peripheral ghrelin enhances sweet taste food consumption and preference, regardless of its caloric content , 2010, Physiology & Behavior.

[14]  S. Ambudkar,et al.  Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity. , 2010, The Journal of clinical investigation.

[15]  T. Lutz,et al.  Brainstem mechanisms of amylin-induced anorexia , 2010, Physiology & Behavior.

[16]  T. Lutz,et al.  Identification of central projections from amylin-activated neurons to the lateral hypothalamus , 2010, Brain Research.

[17]  N. Rowland,et al.  Food demand and meal size in mice with single or combined disruption of melanocortin type 3 and 4 receptors. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

[18]  B. Klapp,et al.  Peripherally injected CCK-8S activates CART positive neurons of the paraventricular nucleus in rats , 2010, Peptides.

[19]  M. Bohlooly-y,et al.  Ghrelin increases intake of rewarding food in rodents , 2010, Addiction biology.

[20]  E. Boyland,et al.  Pharmacological management of appetite expression in obesity , 2010, Nature Reviews Endocrinology.

[21]  M. Lutter,et al.  Ghrelin Increases the Rewarding Value of High-Fat Diet in an Orexin-Dependent Manner , 2010, Biological Psychiatry.

[22]  S. Woods,et al.  Meal-anticipatory glucagon-like peptide-1 secretion in rats. , 2010, Endocrinology.

[23]  Sara R. Jones,et al.  The hypocretin–orexin system regulates cocaine self‐administration via actions on the mesolimbic dopamine system , 2010, The European journal of neuroscience.

[24]  J. Després,et al.  CB1 antagonists for obesity—what lessons have we learned from rimonabant? , 2009, Nature Reviews Endocrinology.

[25]  H. Iwaasa,et al.  Synergistic interaction between neuropeptide Y1 and Y5 receptor pathways in regulation of energy homeostasis. , 2009, European journal of pharmacology.

[26]  Graham J. Dockray,et al.  Cholecystokinin and gut–brain signalling , 2009, Regulatory Peptides.

[27]  S. Woods,et al.  The effects of GLP-1 infusion in the hepatic portal region on food intake , 2009, Regulatory Peptides.

[28]  I. McGregor,et al.  Involvement of hypothalamic peptides in the anorectic action of the CB1 receptor antagonist rimonabant (SR 141716) , 2009, The European journal of neuroscience.

[29]  R. Ritter,et al.  Circulating GLP-1 and CCK-8 reduce food intake by non-vagal mechanisms , 2009, Appetite.

[30]  Takeshi Sakurai,et al.  Orexin/Hypocretin: A Neuropeptide at the Interface of Sleep, Energy Homeostasis, and Reward System , 2009, Pharmacological Reviews.

[31]  D. Richard,et al.  Effects of intracerebroventricular and intra-accumbens melanin-concentrating hormone agonism on food intake and energy expenditure. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[32]  K. Gadde,et al.  Rational Design of a Combination Medication for the Treatment of Obesity , 2009, Obesity.

[33]  M. Kinoshita,et al.  Origin of the earliest correlated neuronal activity in the chick embryo revealed by optical imaging with voltage‐sensitive dyes , 2009, The European journal of neuroscience.

[34]  Daniel Jones.  End of the line for cannabinoid receptor 1 as an anti-obesity target? , 2008, Nature Reviews Drug Discovery.

[35]  D. Thompson,et al.  Cholecystokinin Regulates Expression of Y2 Receptors in Vagal Afferent Neurons Serving the Stomach , 2008, The Journal of Neuroscience.

[36]  C. Berridge,et al.  Hypocretin /orexin preferentially activates caudomedial ventral tegmental area dopamine neurons , 2008, The European journal of neuroscience.

[37]  A. Bonci,et al.  Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons , 2008, The European journal of neuroscience.

[38]  Alain Dagher,et al.  Ghrelin modulates brain activity in areas that control appetitive behavior. , 2008, Cell metabolism.

[39]  V. Hruby,et al.  Effects of selective modulation of the central melanocortin-3-receptor on food intake and hypothalamic POMC expression , 2008, Peptides.

[40]  J. Halford,et al.  Autoradiographic analysis of ghrelin receptors in the rat hypothalamus , 2008, Brain Research.

[41]  A. Ottani,et al.  Regulation of hypothalamic endocannabinoid levels by neuropeptides and hormones involved in food intake and metabolism: Insulin and melanocortins , 2008, Neuropharmacology.

[42]  D. Ffytche,et al.  PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans , 2007, Nature.

[43]  Kyle S. Smith,et al.  Endocannabinoid Hedonic Hotspot for Sensory Pleasure: Anandamide in Nucleus Accumbens Shell Enhances ‘Liking’ of a Sweet Reward , 2007, Neuropsychopharmacology.

[44]  D. Cota.  CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health , 2007, Diabetes/metabolism research and reviews.

[45]  J. Holst.  The physiology of glucagon-like peptide 1. , 2007, Physiological reviews.

[46]  G. Edwards,et al.  Lesion of the lateral parabrachial nucleus attenuates the anorectic effect of peripheral amylin and CCK , 2007, Brain Research.

[47]  K. Herzig,et al.  Food-induced expression of orexin receptors in rat duodenal mucosa regulates the bicarbonate secretory response to orexin-A. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[48]  A. Argiolas,et al.  The cannabinoid antagonist SR 141716A (Rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food , 2007, Neuroscience Letters.

[49]  Y. Choe,et al.  Peptide YY, Cholecystokinin, Insulin and Ghrelin Response to Meal did not Change, but Mean Serum Levels of Insulin is Reduced in Children with Prader-Willi Syndrome , 2007, Journal of Korean medical science.

[50]  A. N. van den Pol,et al.  Cannabinoids Excite Hypothalamic Melanin-Concentrating Hormone But Inhibit Hypocretin/Orexin Neurons: Implications for Cannabinoid Actions on Food Intake and Cognitive Arousal , 2007, The Journal of Neuroscience.

[51]  S. Doran,et al.  Low‐dose Pramlintide Reduced Food Intake and Meal Duration in Healthy, Normal‐Weight Subjects , 2007, Obesity.

[52]  Birgitte Sloth,et al.  Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects. , 2007, American journal of physiology. Endocrinology and metabolism.

[53]  G. Dockray,et al.  Cocaine- and Amphetamine-Regulated Transcript: Stimulation of Expression in Rat Vagal Afferent Neurons by Cholecystokinin and Suppression by Ghrelin , 2007, The Journal of Neuroscience.

[54]  M. Cador,et al.  Opioids for hedonic experience and dopamine to get ready for it , 2007, Psychopharmacology.

[55]  Y. Nagumo,et al.  Implication of protein kinase C in the orexin‐induced elevation of extracellular dopamine levels and its rewarding effect , 2007, The European journal of neuroscience.

[56]  C. Koebnick,et al.  Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36. , 2007, The Journal of clinical endocrinology and metabolism.

[57]  D. Thompson,et al.  Feeding-dependent depression of melanin-concentrating hormone and melanin-concentrating hormone receptor-1 expression in vagal afferent neurones , 2006, Neuroscience.

[58]  J. H. Peters,et al.  Modulation of vagal afferent excitation and reduction of food intake by leptin and cholecystokinin , 2006, Physiology & Behavior.

[59]  B. Levin.  Metabolic sensing neurons and the control of energy homeostasis , 2006, Physiology & Behavior.

[60]  M. Jensen,et al.  Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study , 2006, The Lancet.

[61]  D. Cummings.  Ghrelin and the short- and long-term regulation of appetite and body weight , 2006, Physiology & Behavior.

[62]  T. Horvath,et al.  Cannabinoids, opioids and eating behavior: The molecular face of hedonism? , 2006, Brain Research Reviews.

[63]  H. Fields,et al.  Orexin A in the VTA Is Critical for the Induction of Synaptic Plasticity and Behavioral Sensitization to Cocaine , 2006, Neuron.

[64]  F Xavier Pi-Sunyer,et al.  Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. , 2006, JAMA.

[65]  C. Saper,et al.  Expression of ghrelin receptor mRNA in the rat and the mouse brain , 2006, The Journal of comparative neurology.

[66]  S. Shioda,et al.  Direct Involvement of Orexinergic Systems in the Activation of the Mesolimbic Dopamine Pathway and Related Behaviors Induced by Morphine , 2006, The Journal of Neuroscience.

[67]  A. Kelley,et al.  A proposed hypothalamic–thalamic–striatal axis for the integration of energy balance, arousal, and food reward , 2005, The Journal of comparative neurology.

[68]  H. Jang,et al.  Peptide YY is secreted after oral glucose administration in a gender-specific manner. , 2005, The Journal of clinical endocrinology and metabolism.

[69]  Mohammad A Ghatei,et al.  Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. , 2005, Endocrinology.

[70]  J. Després,et al.  Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. , 2005, The New England journal of medicine.

[71]  L. Heisler,et al.  Serotonergic pathways converge upon central melanocortin systems to regulate energy balance , 2005, Peptides.

[72]  K. Gamber,et al.  Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus , 2005, Neuropharmacology.

[73]  M. Palkovits,et al.  Cocaine- and Amphetamine-Related Transcript Is Involved in the Orexigenic Effect of Endogenous Anandamide , 2005, Neuroendocrinology.

[74]  H. Berthoud,et al.  Brain stem melanocortinergic modulation of meal size and identification of hypothalamic POMC projections. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[75]  Stephen R. Bloom,et al.  The inhibitory effects of peripheral administration of peptide YY3–36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal–brainstem–hypothalamic pathway , 2005, Brain Research.

[76]  S. Doran,et al.  Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes , 2005, Diabetologia.

[77]  A. Rissanen,et al.  Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study , 2005, The Lancet.

[78]  M. Schwartz,et al.  Leptin action in the forebrain regulates the hindbrain response to satiety signals. , 2005, The Journal of clinical investigation.

[79]  R. Batterham,et al.  Peptide YY: a potential therapy for obesity. , 2005, Current drug targets.

[80]  H. Herzog,et al.  Compensatory changes in [125I]-PYY binding in Y receptor knockout mice suggest the potential existence of further Y receptor(s) , 2005, Neuropeptides.

[81]  S. Haj-Dahmane,et al.  The Wake-Promoting Peptide Orexin-B Inhibits Glutamatergic Transmission to Dorsal Raphe Nucleus Serotonin Neurons through Retrograde Endocannabinoid Signaling , 2005, The Journal of Neuroscience.

[82]  J. Quinn,et al.  A bi-directional μ-opioid–opioid connection between the nucleus of the accumbens shell and the central nucleus of the amygdala in the rat , 2004, Brain Research.

[83]  C. Beglinger,et al.  Glucagon-like peptide 1 (GLP-1) and eating , 2004, Physiology & Behavior.

[84]  I. McGregor,et al.  Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake. , 2004, Endocrinology.

[85]  M. Birnbaum,et al.  AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus , 2004, Nature.

[86]  Kanji A. Takahashi,et al.  Cholecystokinin-mediated suppression of feeding involves the brainstem melanocortin system , 2004, Nature Neuroscience.

[87]  D. Carling,et al.  AMP-activated Protein Kinase Plays a Role in the Control of Food Intake* , 2004, Journal of Biological Chemistry.

[88]  D. Thompson,et al.  Expression of Cannabinoid Cb1 Receptors by Vagal Afferent Neurons Is Inhibited by Cholecystokinin , 2022 .

[89]  D. Cummings,et al.  Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans. , 2004, The Journal of clinical endocrinology and metabolism.

[90]  M. Schwartz,et al.  Oxytocin innervation of caudal brainstem nuclei activated by cholecystokinin , 2003, Brain Research.

[91]  J. Rodgers,et al.  The Psychopharmacology of Appetite: Targets for Potential Anti-Obesity Agents , 2003 .

[92]  Mohammad A Ghatei,et al.  Inhibition of food intake in obese subjects by peptide YY3-36. , 2003, The New England journal of medicine.

[93]  J. Holst,et al.  Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes. , 2003, The American journal of clinical nutrition.

[94]  M. McBurney,et al.  The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal , 2003, European Journal of Clinical Nutrition.

[95]  E. H. Goulding,et al.  Hyperactivity and reduced energy cost of physical activity in serotonin 5-HT(2C) receptor mutant mice. , 2003, Diabetes.

[96]  B. Balleine,et al.  The Effect of Lesions of the Basolateral Amygdala on Instrumental Conditioning , 2003, The Journal of Neuroscience.

[97]  H. Haas,et al.  Excitation of Ventral Tegmental Area Dopaminergic and Nondopaminergic Neurons by Orexins/Hypocretins , 2003, The Journal of Neuroscience.

[98]  C. Saper,et al.  The Need to Feed Homeostatic and Hedonic Control of Eating , 2002, Neuron.

[99]  J. Halford,et al.  Orexins and appetite regulation , 2002, Neuropeptides.

[100]  M. Yeomans,et al.  Opioid peptides and the control of human ingestive behaviour , 2002, Neuroscience & Biobehavioral Reviews.

[101]  B. Schneeman,et al.  Plasma cholecystokinin is associated with subjective measures of satiety in women. , 2002, The American journal of clinical nutrition.

[102]  Rachel L. Batterham,et al.  Gut hormone PYY3-36 physiologically inhibits food intake , 2002, Nature.

[103]  Y. Smith,et al.  Cocaine‐ and amphetamine‐regulated transcript peptide projections in the ventral midbrain: Colocalization with γ‐aminobutyric acid, melanin‐concentrating hormone, dynorphin, and synaptic interactions with dopamine neurons , 2002, The Journal of comparative neurology.

[104]  B. Levin,et al.  Metabolic sensors Viewing glucosensing neurons from a broader perspective , 2002, Physiology & Behavior.

[105]  H. Berthoud,et al.  Multiple neural systems controlling food intake and body weight , 2002, Neuroscience & Biobehavioral Reviews.

[106]  S. Bloom,et al.  Food fails to suppress ghrelin levels in obese humans. , 2002, The Journal of clinical endocrinology and metabolism.

[107]  A. Deutch,et al.  Anatomical substrates of orexin–dopamine interactions: lateral hypothalamic projections to the ventral tegmental area , 2002, Neuroscience.

[108]  W. Pan,et al.  Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier , 2002, Journal of Molecular Neuroscience.

[109]  R. Zabielski,et al.  Multiple regulation of peptide YY secretion in the digestive tract , 2002, Peptides.

[110]  H. Grill,et al.  The Neuroanatomical Axis for Control of Energy Balance , 2002, Frontiers in Neuroendocrinology.

[111]  G. Frost,et al.  Ghrelin enhances appetite and increases food intake in humans. , 2001, The Journal of clinical endocrinology and metabolism.

[112]  N. Jamshidi,et al.  Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats , 2001, British journal of pharmacology.

[113]  R. Batterham,et al.  Ghrelin causes hyperphagia and obesity in rats. , 2001, Diabetes.

[114]  E. Air,et al.  Inhibition of central amylin signaling increases food intake and body adiposity in rats. , 2001, Endocrinology.

[115]  A. Astrup,et al.  A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. , 2001, The Journal of clinical endocrinology and metabolism.

[116]  S. Bloom,et al.  Printed in U.S.A. Copyright © 2001 by The Endocrine Society Evidence of an Orexigenic Role for Cocaine- and Amphetamine-Regulated Transcript after Administration into Discrete Hypothalamic Nuclei , 2022 .

[117]  B. Wisse,et al.  A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. , 2001, Diabetes.

[118]  E. Scharrer,et al.  The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema/nucleus of the solitary tract (AP/NTS) lesioned rats , 2001, International Journal of Obesity.

[119]  M. Tschöp,et al.  Post-prandial decrease of circulating human ghrelin levels , 2001, Journal of endocrinological investigation.

[120]  R. Palmiter,et al.  Leptin-regulated endocannabinoids are involved in maintaining food intake , 2001, Nature.

[121]  C. Beglinger,et al.  Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[122]  K. Hosoda,et al.  Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. , 2001, Diabetes.

[123]  M. Nakazato,et al.  A role for ghrelin in the central regulation of feeding , 2001, Nature.

[124]  Yue Feng,et al.  Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass , 2000, Nature Genetics.

[125]  M. Kuhar,et al.  Intra-ventral tegmental area injection of rat cocaine and amphetamine-regulated transcript peptide 55-102 induces locomotor activity and promotes conditioned place preference. , 2000, The Journal of pharmacology and experimental therapeutics.

[126]  C. Beglinger,et al.  Interaction between CCK and a preload on reduction of food intake is mediated by CCK-A receptors in humans. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[127]  Min-Seon Kim,et al.  Investigation of the melanocyte stimulating hormones on food intake Lack of evidence to support a role for the melanocortin-3-receptor , 2000, Brain Research.

[128]  K. Teff.  Nutritional implications of the cephalic-phase reflexes: endocrine responses , 2000, Appetite.

[129]  B. Glenn Stanley,et al.  Brain regions where cholecystokinin suppresses feeding in rats , 2000, Brain Research.

[130]  J. Blundell,et al.  Separate systems for serotonin and leptin in appetite control , 2000, Annals of medicine.

[131]  M. Nakazato,et al.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach , 1999, Nature.

[132]  M. Westerterp-Plantenga,et al.  Blood glucose and meal patterns in time-blinded males, after aspartame, carbohydrate, and fat consumption, in relation to sweetness perception , 1999, British Journal of Nutrition.

[133]  X. Cai,et al.  Hypothalamic orexin expression: modulation by blood glucose and feeding. , 1999, Diabetes.

[134]  P. Currie,et al.  5-HT(2A/2C) receptor antagonists in the paraventricular nucleus attenuate the action of DOI on NPY-stimulated eating. , 1999, Neuroreport.

[135]  J. Holst,et al.  GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[136]  Emmanuel Mignot,et al.  The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene , 1999, Cell.

[137]  Jon T. Willie,et al.  Narcolepsy in orexin Knockout Mice Molecular Genetics of Sleep Regulation , 1999, Cell.

[138]  M. Kuhar,et al.  CART peptides: novel addiction- and feeding-related neuropeptides , 1999, Trends in Neurosciences.

[139]  G. Schwartz,et al.  Central leptin modulates behavioral and neural responsivity to CCK. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[140]  A. Kelley,et al.  Blockade of GABAA receptors in the medial ventral pallidum elicits feeding in satiated rats , 1999, Brain Research.

[141]  C. Saper,et al.  From Lesions to Leptin Hypothalamic Control of Food Intake and Body Weight , 1999, Neuron.

[142]  G. Barsh,et al.  Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area , 1998, The Journal of comparative neurology.

[143]  R. Quirion,et al.  Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains , 1998, The Journal of comparative neurology.

[144]  S. Coppack,et al.  Adipose tissue as an endocrine and paracrine organ , 1998, International Journal of Obesity.

[145]  S. O’Rahilly,et al.  A frameshift mutation in MC4R associated with dominantly inherited human obesity , 1998, Nature Genetics.

[146]  J. Wishart,et al.  Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate. , 1998, The American journal of clinical nutrition.

[147]  C. Saper,et al.  Distributions of leptin receptor mRNA isoforms in the rat brain , 1998, The Journal of comparative neurology.

[148]  A. Grüters,et al.  Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans , 1998, Nature Genetics.

[149]  J. Halford,et al.  Serotonin and Appetite Regulation , 1998 .

[150]  P. J. Larsen,et al.  Hypothalamic CART is a new anorectic peptide regulated by leptin , 1998, Nature.

[151]  J. Simiand,et al.  SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. , 1998, Behavioural pharmacology.

[152]  S. Carr,et al.  Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior , 1998, Cell.

[153]  A. Astrup,et al.  Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. , 1998, The Journal of clinical investigation.

[154]  R. Adan,et al.  Brain Melanocortin Receptors: From Cloning to Function , 1997, Peptides.

[155]  J. Flier,et al.  Divergent Signaling Capacities of the Long and Short Isoforms of the Leptin Receptor* , 1997, The Journal of Biological Chemistry.

[156]  Jian Wang,et al.  Central insulin inhibits hypothalamic galanin and neuropeptide Y gene expression and peptide release in intact rats , 1997, Brain Research.

[157]  R. Steiner,et al.  Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. , 1997, Endocrinology.

[158]  R. M. Gentry,et al.  Comparison of Fos induced in rat brain by GLP-1 and amylin , 1997, Regulatory Peptides.

[159]  T. Wenger,et al.  Arachidonyl ethanolamide (anandamide) activates the parvocellular part of hypothalamic paraventricular nucleus. , 1997, Biochemical and biophysical research communications.

[160]  P. Soubrié,et al.  Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors , 1997, Psychopharmacology.

[161]  S. O’Rahilly,et al.  Congenital leptin deficiency is associated with severe early-onset obesity in humans , 1997, Nature.

[162]  B. Lowell,et al.  Immunohistochemical localization of leptin and uncoupling protein in white and brown adipose tissue. , 1997, Endocrinology.

[163]  K. Moar,et al.  Regulation of leptin receptor and NPY gene expression in hypothalamus of leptin‐treated obese (ob/ob) and cold‐exposed lean mice , 1997, FEBS letters.

[164]  R. Cone,et al.  Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.

[165]  Victor J. Hruby,et al.  Role of melanocortinergic neurons in feeding and the agouti obesity syndrome , 1997, Nature.

[166]  J. Friedman.  The alphabet of weight control , 1997, Nature.

[167]  R. Considine,et al.  Responses of Leptin to Short-Term Fasting and Refeeding in Humans: A Link With Ketogenesis but Not Ketones Themselves , 1996, Diabetes.

[168]  P. Hoogerhout,et al.  Distribution of Lys-γ2-melanocyte-stimulating hormone-(Lys-γ2-MSH)-like immunoreactivity in neuronal elements in the brain and peripheral tissues of the rat , 1996, Brain Research.

[169]  M. Yeomans,et al.  Selective effects of naltrexone on food pleasantness and intake , 1996, Physiology & Behavior.

[170]  R. Considine,et al.  Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance , 1996, The Lancet.

[171]  J. Habener,et al.  Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. , 1996, Endocrinology.

[172]  D. Coscina,et al.  Metergoline potentiates natural feeding and antagonizes the anorectic action of medial hypothalamic 5-hydroxytryptamine , 1996, Pharmacology Biochemistry and Behavior.

[173]  S. Gammeltoft,et al.  A role for melanin-concentrating hormone in the central regulation of feeding behaviour , 1996, Nature.

[174]  L. Tartaglia,et al.  Phenotypes of Mouse diabetes and Rat fatty Due to Mutations in the OB (Leptin) Receptor , 1996, Science.

[175]  D. Smith,et al.  A role for glucagon-like peptide-1 in the central regulation of feeding , 1996, Nature.

[176]  R. Devos,et al.  Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. , 1995, Science.

[177]  A. Levine,et al.  Butorphanol increases food-reinforced operant responding in satiated rats , 1994, Pharmacology Biochemistry and Behavior.

[178]  M. Mortrud,et al.  Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. , 1994, Molecular endocrinology.

[179]  M. Kasuga,et al.  Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice. , 1993, The American journal of physiology.

[180]  S. Woods,et al.  Intraventricular CCK-8 reduces single meal size in the baboon by interaction with type-A CCK receptors. , 1992, The American journal of physiology.

[181]  Adam Drewnowski,et al.  Taste responses and preferences for sweet high-fat foods: Evidence for opioid involvement , 1992, Physiology & Behavior.

[182]  V. Marks,et al.  Gut Hormones in Glucose Homeostasis , 1991, Proceedings of the Nutrition Society.

[183]  S. Leibowitz,et al.  Medial hypothalamic nuclei mediate serotonin's inhibitory effect on feeding behavior , 1990, Pharmacology Biochemistry and Behavior.

[184]  L. Blackshaw,et al.  Effects of cholecystokinin (CCK-8) on two classes of gastroduodenal vagal afferent fibre. , 1990, Journal of the autonomic nervous system.

[185]  H. Kawauchi,et al.  Melanin-concentrating hormone-like immunoreactive material in the rat hypothalamus; characterization and subcellular localization , 1988, Cell and Tissue Research.

[186]  S. Leibowitz,et al.  Deficits in the control of food intake after hypothalamic paraventricular nucleus lesions , 1985, Physiology & Behavior.

[187]  Q. Chen,et al.  [Interaction of vagal stimulation and duodenal acidification in the regulation of pancreatic secretion]. , 1985, Sheng li xue bao : [Acta physiologica Sinica].

[188]  S. Leibowitz,et al.  Feeding and drinking elicited by central injection of neuropeptide Y: Evidence for a hypothalamic site(s) of action , 1985, Brain Research Bulletin.

[189]  T. Crow,et al.  Neuropeptide Y distribution in the rat brain. , 1983, Science.

[190]  T. Hyde,et al.  Effects of area postrema/caudal medial nucleus of solitary tract lesions on food intake and body weight. , 1983, The American journal of physiology.

[191]  A. Herz,et al.  Activation of hypothalamic β-endorphin pools by reward induced by highly palatable food , 1983, Pharmacology Biochemistry and Behavior.

[192]  S. Cooper.  Effects of opiate agonists and antagonists on fluid intake and saccharin choice in the rat , 1983, Neuropharmacology.

[193]  X. Pi-Sunyer,et al.  C-Terminal octapeptide of cholecystokinin decreases food intake in obese men , 1982, Physiology & Behavior.

[194]  J. Louis-Sylvestre,et al.  A fall in blood glucose level precedes meal onset in free-feeding rats , 1980, Neuroscience & Biobehavioral Reviews.

[195]  J. Blundell,et al.  Characterisation of adjustments to the structure of feeding behaviour following pharmacological treatment: Effects of amphetamine and fenfluramine and the antagonism produced by pimozide and methergoline , 1980, Pharmacology Biochemistry and Behavior.

[196]  G. P. Smith,et al.  Cholecystokinin decreases food intake in rats. , 1973, Journal of comparative and physiological psychology.

[197]  E. Boyland,et al.  Pharmacological management of human appetite expression: Evaluating the effects of novel anti-obesity agents on eating behaviour. , 2010 .

[198]  A. M. O R G A N,et al.  Gut hormones in glucose homeostasis , 2005 .

[199]  glucostatique de l’alimentation.  Metabolic and glucostatic control of feeding de l’alimentation , 2005 .

[200]  S. Holtzman.  Tolerance to the stimulant effects of morphine and pentazocine on avoidance responding in the rat , 2004, Psychopharmacologia.

[201]  T. Lutz,et al.  The anorectic hormone amylin contributes to feeding-related changes of neuronal activity in key structures of the gut-brain axis. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[202]  H. Grill,et al.  Printed in U.S.A. Copyright © 2002 by The Endocrine Society Evidence That the Caudal Brainstem Is a Target for the Inhibitory Effect of Leptin on Food Intake , 2022 .

[203]  J. Rehfeld,et al.  The predominant cholecystokinin in human plasma and intestine is cholecystokinin-33. , 2001, The Journal of clinical endocrinology and metabolism.

[204]  X. Cai,et al.  Hypoglycemia activates orexin neurons and selectively increases hypothalamic orexin-B levels: responses inhibited by feeding and possibly mediated by the nucleus of the solitary tract. , 2001, Diabetes.

[205]  T. Kirkham,et al.  Synergistic efects of opioid and cannabinoid antagonists on food intake , 2000, Psychopharmacology.

[206]  健 海老原.  Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action , 2000 .

[207]  S. Carr,et al.  Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. , 1998, Cell.

[208]  R. Wurtman,et al.  Brain Serotonin, Carbohydrate-craving, obesity and depression. , 1996, Advances in experimental medicine and biology.

[209]  J. Blundell,et al.  Pharmacological approaches to appetite suppression. , 1991, Trends in pharmacological sciences.